Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-02-12
1982-01-19
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424311, 424317, 424331, A61K 31215
Patent
active
043117074
ABSTRACT:
This application discloses a process for producing cutaneous vasodilation which comprises the topical administration to an individual with a vasospastic or ischemic condition of an effective dosage of a prostaglandin vasodilator of the natural or synthetic prostaglandin analogs of the PGE, PGA, or PGF.sub..beta. types.
REFERENCES:
patent: 3551554 (1970-12-01), Herschler
patent: 4131738 (1978-12-01), Smith
patent: 4158667 (1979-06-01), Axen
Lowe and Stoughton--J. of Investigative Dermatology, 68:134-137, 1977.
Merck Manual--10th Ed., 1961, pp. 238, 239, 1426-1429.
Conway et al.--Chem. Abst., vol. 83 (1975), p. 91,369e.
Harrison et al.--Chem. Abst., vol. 83 (1975), p. 53,742p.
Williams et al.--Chem. Abst., vol. 88 (1978), p. 183,486x
Birnbaum Jay E.
Dessy Franz
Van Humbeeck Luc
American Cyanamid Company
Schenkman Leonard
LandOfFree
Process for topically producing cutaneous vasodilation for the t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for topically producing cutaneous vasodilation for the t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for topically producing cutaneous vasodilation for the t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1915171